Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063185) titled 'Stratified Testing for Risk Identification using Digital and Blood Evaluations in Prodromal Alzheimer's Disease' on Oct. 6.
Study Type:
Observational
Primary Sponsor:
Institute - Oita University Faculty of Medicine
Condition:
Condition - Mild cognitive impairment and mild dementia due to Alzheimer's disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study tests whether a stepwise (hierarchical) diagnostic pathway that combines a self-administered digital cognitive assessment (MoCA Solo-J) performed in primary care with an Alzheimer's disease blood biomark...